Eisler Capital (UK)’s JPMorgan Chase JPM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.62M Buy
+12,417
New +$2.62M 0.01% 421
2024
Q1
Sell
-56,772
Closed -$10.2M 665
2023
Q4
$9.66M Sell
56,772
-396,504
-87% -$60.1M 0.07% 209
2023
Q3
$65.7M Buy
453,276
+339,321
+298% +$50.9M 0.41% 51
2023
Q2
$16.6M Sell
113,955
-26,643
-19% -$3.66M 0.12% 151
2023
Q1
$18.3M Sell
140,598
-187,019
-57% -$25.6M 0.18% 118
2022
Q4
$43.9M Sell
327,617
-25,363
-7% -$3.21M 2.05% 16
2022
Q3
$36.9M Buy
352,980
+214,311
+155% +$24.6M 1.85% 14
2022
Q2
$15.6M Buy
138,669
+14,716
+12% +$1.82M 0.51% 42
2022
Q1
$16.9M Buy
123,953
+96,810
+357% +$14.3M 0.28% 95
2021
Q4
$4.3M Buy
27,143
+14,160
+109% +$2.33M 0.21% 88
2021
Q3
$2.13M Sell
12,983
-12,206
-48% -$1.91M 0.08% 187
2021
Q2
$3.92M Buy
25,189
+17,087
+211% +$2.68M 0.22% 74
2021
Q1
$1.23M Buy
+8,102
New +$1.17M 0.11% 94

Other funds holding JPM

Eisler Capital (UK)'s JPM Position: Q3 2024 in Review

Eisler Capital (UK) opened a new position in JPMorgan Chase (JPM) in Q3 2024: 12,417 shares worth $2.62M. The stake represents 0.01% of the portfolio and ranks #421 among its holdings. This is a return to the name: Eisler Capital (UK) previously reported a position in JPM as recently as Q4 2023.

Eisler Capital (UK) first reported a position in JPM in Q1 2021 and has held it in 13 quarters since. The position peaked at $65.7M in Q3 2023. 4,201 funds tracked by Wall St. Rank hold JPM as of Q3 2024.

  • Eisler Capital (UK) held 12,417 shares of JPMorgan Chase worth $2.62M as of Q3 2024.
  • JPMorgan Chase was a new Eisler Capital (UK) position in Q3 2024.
  • JPMorgan Chase made up 0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #421 holding.
  • Eisler Capital (UK) first reported a position in JPMorgan Chase in Q1 2021 and has held it in 13 quarters since.
  • Eisler Capital (UK)'s JPMorgan Chase position peaked at $65.7M in Q3 2023.
  • 4,201 funds tracked by Wall St. Rank held JPMorgan Chase as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.